Effect of RC-3095 on vascular calcification in HP-fed CKD mouse. CKD mice were fed with a normal phosphate (0.5%, NP) or high phosphate (1.8%, HP) diet. For assessing the effect of RC-3095 treatment, CKD mice were intraperitoneally injected with RC-3095 (1 mg/kg) or vehicle (0.9% saline) 3 times a week for a total 12 weeks. (a and c) Area of aortic calcification in CKD and sham mice was determined by von-Kossa staining. Scale bar: 50 μm. (b) Total RNA was isolated and analyzed by real-time RT-PCR using the specific primers for mouse GRP and GRP-R. The expression level of these genes in the control (untreated) was set to 1 and the values were normalized to the β-actin mRNA levels. * p < 0.05; ** p < 0.01 vs. sham, #
p < 0.05; ##
p < 0.01vs. NP. (d,e) GRP, GRP-R, Runx2, calponin, Bcl2 and Bad mRNA levels were also examined by real-time RT-PCR. * p <0.05; ** p < 0.01 vs. NP, #
p < 0.05 vs. vehicle. Data shown are the mean ± SD, obtained from at least three independent experiments.